Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Organogenesis Holdings (ORGO) over the last 10 years, with Q3 2025 value amounting to $844000.0.

  • Organogenesis Holdings' Free Cash Flow fell 8622.27% to $844000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$51.7 million, marking a year-over-year decrease of 142781.49%. This contributed to the annual value of $4.2 million for FY2024, which is 3627.35% down from last year.
  • As of Q3 2025, Organogenesis Holdings' Free Cash Flow stood at $844000.0, which was down 8622.27% from -$36.5 million recorded in Q2 2025.
  • Organogenesis Holdings' Free Cash Flow's 5-year high stood at $13.1 million during Q2 2021, with a 5-year trough of -$36.5 million in Q2 2025.
  • For the 5-year period, Organogenesis Holdings' Free Cash Flow averaged around -$1.4 million, with its median value being $1.1 million (2023).
  • In the last 5 years, Organogenesis Holdings' Free Cash Flow skyrocketed by 35525.21% in 2023 and then tumbled by 137750.17% in 2025.
  • Organogenesis Holdings' Free Cash Flow (Quarter) stood at $12.7 million in 2021, then tumbled by 122.45% to -$2.9 million in 2022, then skyrocketed by 355.25% to $7.3 million in 2023, then grew by 3.92% to $7.6 million in 2024, then crashed by 88.86% to $844000.0 in 2025.
  • Its Free Cash Flow stands at $844000.0 for Q3 2025, versus -$36.5 million for Q2 2025 and -$23.6 million for Q1 2025.